Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Oncology

Pharmacology/Therapy

Long-term survival and late complications of intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma

BMC Cancer | Nov 23, 2018 Pharmacology/Therapy

Chemotherapy-free initial treatment of advanced indolent lymphoma has durable effect with low toxicity: Results from two Nordic Lymphoma Group trials with more than 10 years of follow-up

Journal of Clinical Oncology | Nov 22, 2018 Pharmacology/Therapy

Definitive radiotherapy for localized follicular lymphoma staged by ¹⁸F-FDG PET-CT: A collaborative study by ILROG

Blood | Nov 22, 2018 Pharmacology/Therapy

Non-aspirin NSAIDs and contralateral breast cancer risk

International Journal of Cancer | Nov 22, 2018 Pharmacology/Therapy

Two-stage hepatectomy for colorectal liver metastases: Pathologic response to preoperative chemotherapy is associated with second-stage completion and longer survival

Surgery | Nov 22, 2018 Pharmacology/Therapy

Overall survival with palbociclib and fulvestrant in advanced breast cancer

New England Journal of Medicine | Nov 20, 2018 Pharmacology/Therapy

Cardiovascular toxicities associated with immune checkpoint inhibitors: An observational, retrospective, pharmacovigilance study

The Lancet Oncology | Nov 20, 2018 Pharmacology/Therapy

Longitudinal trajectory and characterization of cancer-related cognitive impairment in a nationwide cohort study

Journal of Clinical Oncology | Nov 20, 2018 Pharmacology/Therapy

Pembrolizumab as neoadjuvant therapy before radical cystectomy in patients with muscle-invasive urothelial bladder carcinoma (PURE-01): An open-label, single-arm, phase II study

Journal of Clinical Oncology | Nov 20, 2018 Pharmacology/Therapy

Long-term survival of patients with melanoma with active brain metastases treated with pembrolizumab on a phase II trial

Journal of Clinical Oncology | Nov 20, 2018 Pharmacology/Therapy

« Prev 1 … 266 267 268 269 270 … 375 Next »

Long-term survival and late complications of intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma

Chemotherapy-free initial treatment of advanced indolent lymphoma has durable effect with low toxicity: Results from two Nordic Lymphoma Group trials with more than 10 years of follow-up

Definitive radiotherapy for localized follicular lymphoma staged by ¹⁸F-FDG PET-CT: A collaborative study by ILROG

Non-aspirin NSAIDs and contralateral breast cancer risk

Two-stage hepatectomy for colorectal liver metastases: Pathologic response to preoperative chemotherapy is associated with second-stage completion and longer survival

Overall survival with palbociclib and fulvestrant in advanced breast cancer

Cardiovascular toxicities associated with immune checkpoint inhibitors: An observational, retrospective, pharmacovigilance study

Longitudinal trajectory and characterization of cancer-related cognitive impairment in a nationwide cohort study

Pembrolizumab as neoadjuvant therapy before radical cystectomy in patients with muscle-invasive urothelial bladder carcinoma (PURE-01): An open-label, single-arm, phase II study

Long-term survival of patients with melanoma with active brain metastases treated with pembrolizumab on a phase II trial

Article: TSH Abnormalities and Treatment Algorithms in Primary Care

MD Clip on Diabetes & Urinary ACR: Detecting Kidney Damage Early with Dr Saraogi

Article: How to Diagnose and Differentiate Common Causes of Sudden Vision Loss

30-year-old athlete suffers fatal heart attack—could you have seen this coming?

Eating ultra processed foods may speed up early signs of Parkinson's disease

Long-term survival and late complications of intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma

Chemotherapy-free initial treatment of advanced indolent lymphoma has durable effect with low toxicity: Results from two Nordic Lymphoma Group trials with more than 10 years of follow-up

Definitive radiotherapy for localized follicular lymphoma staged by 18F-FDG PET-CT: A collaborative study by ILROG

Non-aspirin NSAIDs and contralateral breast cancer risk

Two-stage hepatectomy for colorectal liver metastases: Pathologic response to preoperative chemotherapy is associated with second-stage completion and longer survival

Overall survival with palbociclib and fulvestrant in advanced breast cancer

Cardiovascular toxicities associated with immune checkpoint inhibitors: An observational, retrospective, pharmacovigilance study

Longitudinal trajectory and characterization of cancer-related cognitive impairment in a nationwide cohort study

Pembrolizumab as neoadjuvant therapy before radical cystectomy in patients with muscle-invasive urothelial bladder carcinoma (PURE-01): An open-label, single-arm, phase II study

Long-term survival of patients with melanoma with active brain metastases treated with pembrolizumab on a phase II trial

Article: TSH Abnormalities and Treatment Algorithms in Primary Care

MD Clip on Diabetes & Urinary ACR: Detecting Kidney Damage Early with Dr Saraogi

Article: How to Diagnose and Differentiate Common Causes of Sudden Vision Loss

30-year-old athlete suffers fatal heart attack—could you have seen this coming?

Eating ultra processed foods may speed up early signs of Parkinson's disease

Select Specialty

Select Topic

Definitive radiotherapy for localized follicular lymphoma staged by ¹⁸F-FDG PET-CT: A collaborative study by ILROG